相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project
Mattia D'Agostino et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
Francesca Di Rosa et al.
FRONTIERS IN IMMUNOLOGY (2021)
Improving the accuracy of gastrointestinal neuroendocrine tumor grading with deep learning
Darshana Govind et al.
SCIENTIFIC REPORTS (2020)
Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study
Balazs Acs et al.
LABORATORY INVESTIGATION (2019)
Genomic complexity of multiple myeloma and its clinical implications
Salomon Manier et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation
Gunjan L. Shah et al.
LEUKEMIA & LYMPHOMA (2017)
Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients
Scott Ely et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2017)
Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation
Fabian Bock et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
Antonio Palumbo et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Niccolo Bolli et al.
NATURE COMMUNICATIONS (2014)
Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
E. C. Inwald et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survival
Jeremy T. Larsen et al.
BLOOD (2011)
Initial genome sequencing and analysis of multiple myeloma
Michael A. Chapman et al.
NATURE (2011)
Ki67 in breast cancer: prognostic and predictive potential
Rinat Yerushalmi et al.
LANCET ONCOLOGY (2010)
Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia
Jean-Marie Bruey et al.
LEUKEMIA RESEARCH (2010)
Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma
Adi Broyde et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Plasma cell growth fraction using Ki-67 antigen expression identifies a subgroup of multiple myeloma patients displaying short survival within the ISS stage I
Thomas Gastinne et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
John D. Shaughnessy et al.
BLOOD (2007)
Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma
R. Fonseca et al.
LEUKEMIA (2006)
The molecular classification of multiple myeloma
Fenghuang Zhan et al.
BLOOD (2006)
Ki-67 proliferation index - Correlation with prognostic parameters and outcome in multiple myeloma
MG Alexandrakis et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2004)
Cell proliferation of myeloma plasma cells: Comparison of the blood and marrow compartments
S Kumar et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death
DP Steensma et al.
BLOOD (2001)
分享论文
